[OncoHost in Times of Israel] Startup develops blood test that aims to undermine tumors’ resilience Feb 10, 2020 | News Center Share: ONCOHOST, founded by the Technion’s Yuval Shaked, is performing clinical trials; goal is to predict treatments’ effectiveness and determine how to improve them, for each patient Read more here.